Project Grant HT94252410955
Award Date
11/1/24
Completion Date
10/31/25
Dollars Obligated
$154K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Rochester, NY 14611, USA
Similar Awards
The University of Rochester received a $812,602 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "IMAGING CANCER MICROENVIRONMENT HOT SPOTS INVOLVED IN PROGRESSION OF MYELODYSPLASTIC SYNDROMES." The research, which will take place from May 2024 to May 2027, aims to improve understanding of the cancer microenvironment and its role in the progression of myelodysplastic syndromes, a group of...
The University of Rochester received a $385,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The two-year award, issued on May 1, 2021 and concluding on April 30, 2023, will support the development of UR238, a small-molecule inhibitor of HE4 being investigated for treatment of ovarian cancer. Through this funding, the University of Rochester will conduct research towards transforming...
This Project Grant award in the amount of $308,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Rochester. The grant is funding a research project to investigate "INVESTIGATING MICROGLIAL REMODELING OF NEURAL CIRCUITS IN PREGNANCY" over a 2-year period from November 15, 2023 to November 14, 2025. The project aims to advance scientific understanding of the role of microglia, a type of immune...
The University of Rochester was awarded a $1,829,300.00 Project Grant from the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from August 1, 2024 to July 31, 2027, will support advanced biomedical research focused on "Mechanistic Insight into the Airborne Hazards Exposure-Related Development of Neurological Disorders." As a leading research university, the...
The University of Rochester will receive $693,000 in funding from the Department of the Army Medical Command through August 31, 2025 for the project "Cooperative Events in the Evolution of Monosomy 7 Myelodysplastic Syndrome." This Project Grant was awarded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care through innovative solutions for battlefield medicine and other health...
The University of Rochester was awarded a $6,292,954 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "Monitoring and Mitigation of Neurological Injuries to Optimize Resilience After Repetitive Head Impacts (MONITOR RHI)," supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The grant, with a period...
The Department of the Army Medical Command awarded a $1.5 million Project Grant to the University of Nebraska Medical Center to support research targeting nuclear importins in pancreatic ductal adenocarcinoma (PDAC) under the Military Medical Research and Development program. The three-year award beginning July 1, 2022 will fund research exploring medical solutions for pancreatic cancer through investigation of nuclear transport proteins that mediate entry of molecules into the cell nucleus....
This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $1,348,041.00 to the Regents of the University of Minnesota to develop a RET-specific proteomic assay from circulating tumor cells in lethal prostate cancer. The award began on Mar 1, 2024 and is scheduled for completion by Feb 28, 2027. This research aims to transform health care for military service members and the general public through innovative...
The Department of the Army Medical Command awarded Duke University a $472,184 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2024 to exploit ferropotosis for the treatment of RB1-deficient lethal prostate cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...